Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Hirakawa

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Auris, Nasus, Larynx|July 21, 2016
Treatment results of alternating chemoradiotherapy with early assessment for advanced laryngeal cancer: A multi-institutional phase II studyYusuke Nakata, Kei Ijichi, Nobuhiro Hanai, et al.
Auris, Nasus, Larynx|November 12, 2021
Therapeutic efficacy of selective intraarterial chemoradiotherapy with docetaxel and nedaplatin for human papilloma virus-negative oropharyngeal cancerJoichi Heianna, Wataru Makino, Hitoshi Hirakawa, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|December 31, 2018
Staging and prognosis of oropharyngeal carcinoma according to the 8th Edition of the American Joint Committee on Cancer Staging Manual in human papillomavirus infectionYukashi Yamashita, Taro Ikegami, Hitoshi Hirakawa, et al.
Asia-Pacific Journal of Clinical Oncology|August 6, 2013
Prognostic factors and outcomes for salvage surgery in patients with recurrent squamous cell carcinoma of the tongueMitsuo Goto, Nobuhiro Hanai, Taijiro Ozawa, et al.
The Tokai Journal of Experimental and Clinical Medicine|September 29, 2004
Feasibility of fiberoptic bronchoscopy for small infants including newbornsTakako Nakano, Masahiro Shikada, Masahiro Nomura, et al.
Journal of the Egyptian National Cancer Institute|December 20, 2021
Patterns of recurrence after low-dose postoperative radiotherapy for head and neck squamous cell carcinomaWataru Makino, Joichi Heianna, Kazuki Ishikawa, et al.
Journal of Cancer Research and Therapeutics|June 7, 2019
Hypopharyngeal cancer risk in Japanese: Genetic polymorphisms related to the metabolism of alcohol- and tobacco-associated carcinogensYukashi Yamashita, Taro Ikegami, Mikio Suzuki, et al.
Anticancer Research|June 4, 2020
Induction Chemotherapy in Hypopharyngeal Cancer: Influence of DNA Repair Gene PolymorphismsHitoshi Hirakawa, Taro Ikegami, Satoe Azechi, et al.
Current Oncology (Toronto, Ont.)|June 27, 2023
Biomarkers for Predicting Anti-Programmed Cell Death-1 Antibody Treatment Effects in Head and Neck CancerKatsunori Tanaka, Hitoshi Hirakawa, Mikio Suzuki, et al.
Viruses|October 26, 2021
Development of Antibodies against HPV-6 and HPV-11 for the Study of Laryngeal PapillomaTaro Ikegami, Norimoto Kise, Hidetoshi Kinjyo, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Auris, Nasus, Larynx|July 21, 2016
Treatment results of alternating chemoradiotherapy with early assessment for advanced laryngeal cancer: A multi-institutional phase II studyYusuke Nakata, Kei Ijichi, Nobuhiro Hanai, et al.
Auris, Nasus, Larynx|November 12, 2021
Therapeutic efficacy of selective intraarterial chemoradiotherapy with docetaxel and nedaplatin for human papilloma virus-negative oropharyngeal cancerJoichi Heianna, Wataru Makino, Hitoshi Hirakawa, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|December 31, 2018
Staging and prognosis of oropharyngeal carcinoma according to the 8th Edition of the American Joint Committee on Cancer Staging Manual in human papillomavirus infectionYukashi Yamashita, Taro Ikegami, Hitoshi Hirakawa, et al.
Asia-Pacific Journal of Clinical Oncology|August 6, 2013
Prognostic factors and outcomes for salvage surgery in patients with recurrent squamous cell carcinoma of the tongueMitsuo Goto, Nobuhiro Hanai, Taijiro Ozawa, et al.
The Tokai Journal of Experimental and Clinical Medicine|September 29, 2004
Feasibility of fiberoptic bronchoscopy for small infants including newbornsTakako Nakano, Masahiro Shikada, Masahiro Nomura, et al.
Journal of the Egyptian National Cancer Institute|December 20, 2021
Patterns of recurrence after low-dose postoperative radiotherapy for head and neck squamous cell carcinomaWataru Makino, Joichi Heianna, Kazuki Ishikawa, et al.
Journal of Cancer Research and Therapeutics|June 7, 2019
Hypopharyngeal cancer risk in Japanese: Genetic polymorphisms related to the metabolism of alcohol- and tobacco-associated carcinogensYukashi Yamashita, Taro Ikegami, Mikio Suzuki, et al.
Anticancer Research|June 4, 2020
Induction Chemotherapy in Hypopharyngeal Cancer: Influence of DNA Repair Gene PolymorphismsHitoshi Hirakawa, Taro Ikegami, Satoe Azechi, et al.
Current Oncology (Toronto, Ont.)|June 27, 2023
Biomarkers for Predicting Anti-Programmed Cell Death-1 Antibody Treatment Effects in Head and Neck CancerKatsunori Tanaka, Hitoshi Hirakawa, Mikio Suzuki, et al.
Viruses|October 26, 2021
Development of Antibodies against HPV-6 and HPV-11 for the Study of Laryngeal PapillomaTaro Ikegami, Norimoto Kise, Hidetoshi Kinjyo, et al.
Pageof 9